CVS HEALTH Corp

CVS

CVS HEALTH Corp

CVS

Insider Sentiment (TTM):

Last Purchase:2025-06-05Last Sale:2026-05-21Shares Purchased (TTM):0Shares Sold (TTM):447,513

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:1,023,129,658Shares Outstanding:1,273,000,000Institutional Ownership Pct.:80.37%

Earnings Market Reaction:

Filing Date:2026-05-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Retail-Drug Stores and Proprietary Stores

GRDN PETS CANN AIXN

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Cash And Cash Equivalents At Carrying Value	9,542	8,453	9,098	11,787	10,076	8,586	6,875	12,507	9,801	8,196	13,043	13,807
Short Term Investments	2,260	2,145	2,134	2,386	2,578	2,407	2,805	3,755	3,288	3,259	3,145	3,080
Accounts Receivable Net Current	40,992	39,779	43,857	40,651	39,625	36,469	36,179	32,385	32,217	35,227	32,927	29,546
Inventory Net	17,770	19,246	18,962	17,447	17,385	18,107	17,649	16,068	16,346	18,025	17,954	17,291
Other Assets Current	4,253	5,091	3,058	3,378	3,527	3,076	3,835	5,237	5,821	3,151	3,074	3,412
Assets Of Disposal Group Including Discontinued Op…	-	-	-	-	-	-	-	-	-	0	0	620
Assets Current	74,817	74,714	77,109	75,649	73,191	68,645	67,343	69,952	67,473	67,858	70,143	67,756
Long Term Investments	32,407	32,669	31,553	29,858	28,906	28,934	28,939	25,028	24,074	23,019	21,667	22,114
Property Plant And Equipment And Finance Lease Rig…	13,037	13,083	12,838	12,825	12,856	12,993	12,728	13,032	13,037	13,183	13,022	13,001
Operating Lease Right Of Use Asset	14,741	14,973	15,271	15,512	15,704	15,944	16,231	16,901	17,045	17,252	17,564	17,703
Goodwill	85,478	85,478	85,478	91,203	91,203	91,272	91,272	91,272	91,272	91,272	91,261	91,260
Intangible Assets Net Excluding Goodwill	25,070	25,508	25,984	26,224	26,570	27,323	27,817	28,311	28,770	29,234	29,624	30,118
Separate Account Assets	-	1,994	1,934	1,858	1,924	3,311	3,334	3,187	3,271	3,250	3,200	3,267
Other Assets Noncurrent	7,424	5,119	5,160	5,214	5,231	4,793	4,763	4,798	4,801	4,660	4,825	4,852
Assets	252,974	253,538	255,327	258,343	255,585	253,215	252,427	252,481	249,743	249,728	251,306	250,071
Liabilities
Accounts Payable Trade Current	16,922	17,641	17,764	17,258	16,534	15,892	15,713	14,416	13,717	14,897	14,874	13,367
Liability For Claims And Claims Adjustment Expense	-	-	-	-	-	-	-	-	-	-	12,550	11,998
Other Policyholder Funds	-	-	-	-	-	-	913	1,051	1,081	1,326	1,440	1,411
Accrued Liabilities Current	22,258	22,387	23,415	23,101	22,369	20,810	20,174	21,163	22,350	23,515	22,571	22,831
Operating Lease Liability Current	1,904	1,737	1,909	1,906	1,909	1,751	1,912	1,911	1,906	1,741	1,741	1,706
Short Term Borrowings	-	0	1,247	3,040	1,259	2,119	800	0	2,719	200	-	1,000
Long Term Debt And Capital Lease Obligations Curre…	2,580	4,068	4,081	6,160	4,411	3,624	4,910	3,731	3,731	2,772	2,132	1,402
Liabilities Current	86,406	88,692	92,695	94,162	88,961	84,609	84,627	81,386	83,319	79,189	81,553	79,206
Operating Lease Liability Noncurrent	13,330	13,643	14,007	14,328	14,594	14,899	15,258	15,537	15,742	16,034	16,441	16,609
Long Term Debt And Capital Lease Obligations	60,531	60,502	60,508	57,290	59,040	60,527	59,824	62,643	57,694	58,638	59,782	61,419
Deferred Income Tax Liabilities Net	3,771	3,832	3,547	3,603	3,664	3,806	3,632	4,052	4,184	4,311	4,250	4,588
Liabilities Of Disposal Group Including Discontinu…	-	-	-	-	-	-	-	-	-	0	0	208
Separate Accounts Liability	-	1,994	1,934	1,858	1,924	3,311	3,334	3,187	3,271	3,250	3,200	3,267
Other Liabilities Noncurrent	6,707	4,777	4,759	4,782	5,419	5,431	5,484	5,526	6,205	6,211	6,237	6,321
Liabilities	175,337	178,156	182,217	180,792	178,475	177,485	177,321	177,370	175,593	173,092	176,796	177,069
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stocks Including Additional Paid In Capital	50,679	50,402	50,181	50,020	49,837	49,661	49,510	49,371	49,209	48,992	48,829	48,649
Treasury Stock Common Value	-36,706	-36,790	-36,776	-36,849	-36,735	-36,818	-36,813	-36,919	-36,773	-33,838	-33,831	-33,933
Retained Earnings Accumulated Deficit	63,282	61,196	59,107	63,936	63,768	62,837	62,038	62,797	61,873	61,604	60,343	58,868
Accumulated Other Comprehensive Income Loss Net Of…	201	406	416	272	59	-120	209	-319	-341	-297	-1,004	-858
Stockholders Equity	77,456	75,214	73,110	77,551	76,929	75,560	74,944	74,930	74,150	76,461	74,510	72,726
Minority Interest	181	168	182	172	181	170	162	181	182	175	173	276
Liabilities And Stockholders Equity	252,974	253,538	255,327	258,343	255,585	253,215	252,427	252,481	249,743	249,728	251,306	250,071
Preferred Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Preferred Stock Shares Authorized	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	3,200	3,200	3,200	3,200	3,200	3,200	3,200	3,200	3,200	3,200	3,200	3,200
Common Stock Shares Issued	1,788	1,787	1,786	1,785	1,779	1,778	1,777	1,777	1,771	1,768	1,767	1,764
Shares Outstanding	1,273	1,271	1,270	1,267	1,262	1,260	1,258	1,256	1,252	1,288	1,287	1,282
Treasury Stock Common Shares	515	516	516	518	517	518	519	521	519	480	480	482

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	4.74%	20.12%	24.81%	-	-	-	-	-	-	-	-	-
2025	-12.41%	-4.15%	-10.78%	14.81%	20.64%	32.88%	-3.19%	-3.57%	-2.48%	2.93%	-2.92%	9.39%
2024	-1.37%	8.99%	5.79%	1.36%	8.69%	1.15%	-2.86%	-27.79%	-10.33%	4.92%	0.70%	7.81%
2023	-	-	-	-11.90%	-6.88%	-8.86%	1.00%	14.59%	7.50%	-2.91%	4.88%	-10.81%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	0.87	0.84	0.83	0.80	0.82	0.81	0.80	0.86	0.81	0.86	0.86	0.86
Quick Ratio	0.66	0.63	0.63	0.62	0.63	0.60	0.59	0.66	0.61	0.63	0.64	0.64
Working Capital	-11.59B	-13.98B	-15.59B	-18.51B	-15.77B	-15.96B	-17.28B	-11.43B	-15.85B	-11.33B	-11.41B	-11.45B
Leverage & Debt
Debt to Equity	2.26	2.36	2.49	2.33	2.32	2.34	2.37	2.37	2.37	2.26	2.37	2.43
Interest Coverage TTM	1.29	1.00	0.82	1.50	1.62	1.45	3.29	4.37	4.51	5.17	5.57	2.68
Debt Ratio	0.69	0.70	0.71	0.70	0.70	0.70	0.70	0.70	0.70	0.69	0.70	0.71
Efficiency & Turnover
Asset Turnover TTM	0.86	0.99	0.97	1.08	1.08	0.92	1.30	1.28	1.33	1.50	1.22	1.10
Days Sales Outstanding TTM	67.63	55.68	59.39	48.16	48.13	56.52	38.50	35.11	33.87	31.88	36.62	39.38
Receivables Turnover TTM	5.40	6.56	6.15	7.58	7.58	6.46	9.48	10.40	10.78	11.45	9.97	9.27
Per Share Metrics
Diluted EPS TTM	2.29	1.39	0.35	3.55	4.17	3.66	3.98	5.71	5.79	6.47	6.71	2.32
Free Cash Flow Per Share TTM	5.81	6.16	4.96	3.78	4.71	5.02	1.34	4.20	6.46	8.09	8.78	13.78
Dividend Per Share TTM	2.67	2.68	2.67	2.67	2.67	2.68	2.63	2.59	2.53	2.44	2.39	2.35
Margin Metrics
Gross Profit Margin TTM	-3.68%	11.50%	11.62%	22.94%	23.17%	10.90%	36.37%	34.71%	34.49%	39.32%	28.39%	21.30%
Operating Profit Margin TTM	2.74%	1.86%	2.00%	3.24%	3.53%	3.68%	2.91%	3.85%	3.85%	3.84%	4.75%	2.44%
Net Profit Margin TTM	1.35%	0.71%	0.18%	1.63%	1.93%	1.99%	1.53%	2.23%	2.25%	2.33%	2.93%	1.13%
Growth Metrics
Net Revenue Growth (1Y)	-20.13%	7.94%	-24.92%	-14.02%	-16.50%	-35.29%	10.95%	22.34%	25.77%	57.88%	66.68%	53.56%
Net Income Growth (1Y)	-44.35%	-61.68%	-91.03%	-37.23%	-28.14%	-44.70%	-42.03%	140.97%	78.48%	92.84%	164.28%	-63.96%
EPS Growth (1Y)	-44.88%	-61.92%	-91.10%	-37.72%	-28.19%	-43.56%	-40.75%	146.15%	81.74%	96.89%	170.03%	-63.12%
Valuation Metrics
P/E TTM	30.72	55.57	206.06	18.56	15.39	11.48	14.63	9.46	12.44	10.94	9.26	26.30
P/B TTM	1.16	1.30	1.27	1.08	1.05	0.70	0.98	0.91	1.23	1.19	1.08	1.08
P/S TTM	0.41	0.39	0.38	0.30	0.30	0.23	0.22	0.21	0.28	0.26	0.27	0.30
Market Cap	90.07B	98.25B	92.73B	83.73B	81.08B	52.96B	73.37B	67.98B	91.21B	91.26B	80.14B	78.45B
Enterprise Value	143.42B	154.11B	149.21B	138.19B	135.44B	110.35B	131.76B	121.53B	145.25B	144.35B	128.68B	128.15B
Calculated Values
Free Cash Flow TTM	7.39B	7.81B	6.29B	4.78B	5.94B	6.33B	1.69B	5.27B	8.14B	10.40B	11.30B	17.67B
Net Debt	53.34B	55.86B	56.48B	54.47B	54.36B	57.39B	58.39B	53.55B	54.04B	53.09B	48.54B	49.69B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-05-21Sale

Owner: Robbins, Larry

Title: -

Shares: 370,462

Price/Share: $93.45

Value: $34,619,673.90

Shares Owned: 4,824,799

Relationship: Director

Ownership: Indirect

2026-05-08Sale

Owner: Mandadi, Tilak

Title: EVP, Chief Exp & Tech Officer

Shares: 69,551

Price/Share: $89.58

Value: $6,230,378.58

Shares Owned: 10,133

Relationship: Officer

Ownership: Direct

2025-08-20Sale

Owner: Finucane, Anne A.

Title: -

Shares: 7,500

Price/Share: $71.02

Value: $532,650.00

Shares Owned: 22,156

Relationship: Director

Ownership: Indirect

2025-06-05Purchase

Owner: Sansone, Guy P

Title: -

Shares: 1,570

Price/Share: $63.70

Value: $100,009.00

Shares Owned: 12,007

Relationship: Director

Ownership: Direct

2025-05-06Sale

Owner: Robbins, Larry

Title: -

Shares: 150,000

Price/Share: $66.67

Value: $10,000,500.00

Shares Owned: 8,196,799

Relationship: Director

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-05-21	Robbins, Larry	Director	-	Indirect	Sale	370,462	93.45	$34,619,673.90	4,824,799	4
2026-05-08	Mandadi, Tilak	Officer	EVP, Chief Exp & Tech Officer	Direct	Sale	69,551	89.58	$6,230,378.58	10,133	4
2025-08-20	Finucane, Anne A.	Director	-	Indirect	Sale	7,500	71.02	$532,650.00	22,156	4
2025-06-05	Sansone, Guy P	Director	-	Direct	Purchase	1,570	63.70	$100,009.00	12,007	4
2025-05-06	Robbins, Larry	Director	-	Indirect	Sale	150,000	66.67	$10,000,500.00	8,196,799	4
2025-03-05	Clark, James David	Officer	SVP, Cont & Chief Acct Officer	Direct	Sale	7,513	66.35	$498,487.55	8,394	4
2025-02-18	Mahoney, Michael F	Director	-	Direct	Purchase	30,000	66.70	$2,001,000.00	39,356	4
2025-01-23	Nelson, Steven H	Officer	EVP and President, Aetna	Indirect	Purchase	24	53.70	$1,288.80	24	4
2024-10-23	Capozzi, Heidi B	Officer	EVP and Chief People Officer	Indirect	Purchase	35	56.85	$1,989.75	85	4
2024-05-02	Mahoney, Michael F	Director	-	Direct	Purchase	9,181	54.49	$500,272.69	9,356	4
2024-05-02	Ludwig, Edward J	Director	-	Direct	Purchase	1,000	53.88	$53,880.00	21,630	4
2024-02-16	Shah, Prem S	Officer	EVP and Pres-Pharm, Consumer W	Direct	Sale	29,473	76.95	$2,267,947.35	39,765	4
2023-11-03	Ludwig, Edward J	Director	-	Direct	Purchase	2,000	70.47	$140,940.00	20,630	4
2023-08-03	Clark, James David	Officer	SVP, Cont & Chief Acct Officer	Direct	Sale	25,759	74.87	$1,928,595.80	4,698	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

80.37%

Inst. Shares: 1,023,129,658

Shares Outstanding: 1,273,000,000

2025-12-31

85.99%

Inst. Shares: 1,089,460,438

Shares Outstanding: 1,267,000,000

2025-09-30

82.89%

Inst. Shares: 1,051,860,300

Shares Outstanding: 1,269,000,000

2025-06-30

82.82%

Inst. Shares: 1,048,561,703

Shares Outstanding: 1,266,000,000

2025-03-31

80.85%

Inst. Shares: 1,019,581,486

Shares Outstanding: 1,261,000,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	1,023,129,658	1,273,000,000	80.37%
2025-12-31	1,089,460,438	1,267,000,000	85.99%
2025-09-30	1,051,860,300	1,269,000,000	82.89%
2025-06-30	1,048,561,703	1,266,000,000	82.82%
2025-03-31	1,019,581,486	1,261,000,000	80.85%
2024-12-31	990,771,970	1,259,000,000	78.70%
2024-09-30	947,779,153	1,259,000,000	75.28%
2024-06-30	967,967,219	1,256,000,000	77.07%
2024-03-31	927,091,292	1,260,000,000	73.58%
2023-12-31	953,331,910	1,285,000,000	74.19%
2023-09-30	920,451,160	1,287,000,000	71.52%
2023-06-30	907,335,695	1,283,000,000	70.72%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

CVS HEALTH Corp (CVS) — SEC Financial Statements & Analysis

CVS HEALTH Corp (CVS) is a retail-drug stores and proprietary stores company, incorporated in DE. CVS HEALTH Corp trades on CVS: NYSE as: CVS. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), CVS HEALTH Corp reported a -20.13% year-over-year revenue growth, a Gross Profit Margin of -3.68% (TTM), a Debt-to-Equity ratio of 2.26x, a Price-to-Sales (P/S) ratio of 0.41x (TTM), a Price-to-Book (P/B) ratio of 1.16 (TTM), at a market cap of $90.07B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -20.13%
Gross Profit Margin TTM: -3.68%
Debt To Equity: 2.26x
P/S TTM: 0.41x
P/B TTM: 1.16
Market Cap: $90.07B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is CVS HEALTH Corp in?

CVS HEALTH Corp (CVS) operates in the Retail-Drug Stores and Proprietary Stores industry.

What is CVS's market cap?

CVS HEALTH Corp (CVS) has a market capitalization of $90.07B as of 2026-03-31.

What is CVS's P/E ratio?

CVS HEALTH Corp (CVS)'s trailing twelve month P/E ratio is 30.72x as of 2026-03-31.

What exchange does CVS trade on?

CVS HEALTH Corp (CVS) trades on the CVS: NYSE.

Where is CVS HEALTH Corp incorporated?

CVS HEALTH Corp is incorporated in DE.

CVS HEALTH Corp (CVS) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.